These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1403049)

  • 1. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.
    Smith MA; Adamson PC; Balis FM; Feusner J; Aronson L; Murphy RF; Horowitz ME; Reaman G; Hammond GD; Fenton RM
    J Clin Oncol; 1992 Nov; 10(11):1666-73. PubMed ID: 1403049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
    Adamson PC; Widemann BC; Reaman GH; Seibel NL; Murphy RF; Gillespie AF; Balis FM
    Clin Cancer Res; 2001 Oct; 7(10):3034-9. PubMed ID: 11595692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.
    Lee JS; Newman RA; Lippman SM; Huber MH; Minor T; Raber MN; Krakoff IH; Hong WK
    J Clin Oncol; 1993 May; 11(5):959-66. PubMed ID: 8487058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
    Adamson PC; Reaman G; Finklestein JZ; Feusner J; Berg SL; Blaney SM; O'Brien M; Murphy RF; Balis FM
    J Clin Oncol; 1997 Nov; 15(11):3330-7. PubMed ID: 9363862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
    Adamson PC
    Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
    Rizvi NA; Marshall JL; Ness E; Yoe J; Gill GM; Truglia JA; Loewen GR; Jaunakais D; Ulm EH; Hawkins MJ
    Clin Cancer Res; 1998 Jun; 4(6):1437-42. PubMed ID: 9626460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
    ; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP
    J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in the oral bioavailability of all-trans-retinoic acid.
    Adamson PC; Pitot HC; Balis FM; Rubin J; Murphy RF; Poplack DG
    J Natl Cancer Inst; 1993 Jun; 85(12):993-6. PubMed ID: 8388479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
    Adamson PC
    Leukemia; 1994 Nov; 8(11):1813-6. PubMed ID: 7967727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
    Muindi JR; Frankel SR; Huselton C; DeGrazia F; Garland WA; Young CW; Warrell RP
    Cancer Res; 1992 Apr; 52(8):2138-42. PubMed ID: 1559217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.
    Rigas JR; Francis PA; Muindi JR; Kris MG; Huselton C; DeGrazia F; Orazem JP; Young CW; Warrell RP
    J Natl Cancer Inst; 1993 Dec; 85(23):1921-6. PubMed ID: 8230282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Chen GQ; Shen ZX; Wu F; Han JY; Miao JM; Zhong HJ; Li XS; Zhao JQ; Zhu J; Fang ZW; Chen SJ; Chen Z; Wang ZY
    Leukemia; 1996 May; 10(5):825-8. PubMed ID: 8656678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.
    Miller VA; Rigas JR; Benedetti FM; Verret AL; Tong WP; Kris MG; Gill GM; Loewen GR; Truglia JA; Ulm EH; Warrell RP
    Clin Cancer Res; 1996 Mar; 2(3):471-5. PubMed ID: 9816192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.
    Creemers GJ; Gerrits CJ; Eckardt JR; Schellens JH; Burris HA; Planting AS; Rodriguez GI; Loos WJ; Hudson I; Broom C; Verweij J; Von Hoff DD
    J Clin Oncol; 1997 Mar; 15(3):1087-93. PubMed ID: 9060549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
    Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
    Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans-retinoic acid and pseudotumor cerebri.
    Visani G; Manfroi S; Tosi P; Martinelli G
    Leuk Lymphoma; 1996 Nov; 23(5-6):437-42. PubMed ID: 9031073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.
    Malempati S; Nicholson HS; Reid JM; Blaney SM; Ingle AM; Krailo M; Stork LC; Melemed AS; McGovern R; Safgren S; Ames MM; Adamson PC;
    J Clin Oncol; 2007 Apr; 25(12):1505-11. PubMed ID: 17442992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
    Villablanca JG; Khan AA; Avramis VI; Seeger RC; Matthay KK; Ramsay NK; Reynolds CP
    J Clin Oncol; 1995 Apr; 13(4):894-901. PubMed ID: 7707116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association.
    Visani G; Bontempo G; Manfroi S; Pazzaglia A; D'Alessandro R; Tura S
    Haematologica; 1996; 81(2):152-4. PubMed ID: 8641645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.